Tecvayli 153 mg/1.7 mL (90 mg/mL) Injection

Tecvayli 153 mg/1.7 mL (90 mg/mL) is an antiviral medication belonging to the integrase inhibitor class. It is used to treat adults infected with the human immunodeficiency virus 1 (HIV-1), a virus that causes acquired immunodeficiency syndrome (AIDS), and who do not have evidence of current or past viral resistance to emtricitabine or tenofovir.

Tecvayli (teclistamab-cqyv) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory multiple myeloma in adults who have received four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 monoclonal antibody.

Tecvayli 153 mg/1.7 mL (90 mg/mL) Injection​ You can contact us to find out the price:

Contact for detailed information
Important Notice: We do not have any activities such as drug sales, drug supply or drug promotion on our site. In addition, there is no help or counseling service on medical matters on our site. All information on the site has been prepared for patients and doctors to have information about drugs. Our site is not under legal responsibility for the incomplete or not updated information on our site. Our users entering the site are deemed to have accepted these conditions. Please consult your doctor before using medication.
Related Keywords

Contact Now

You can contact us immediately to get information about our products and services, and to get answers to your questions.

Contact Now